InvestorsHub Logo
Followers 0
Posts 438
Boards Moderated 0
Alias Born 09/22/2010

Re: None

Monday, 02/14/2011 8:47:02 PM

Monday, February 14, 2011 8:47:02 PM

Post# of 146242
Medivir news today - both good and bad

http://www.medivir.se/v4/en/ir_media/pressrelease.cfm

Pretty impressive partner (JNJ).
The good news is that companies like JNJ are interested in this space. The bad news is JNJ must have looked at all competing programs before picking Medivir. They obviously passed on you know who. The other bad news is there is a new, well-capitalized player in the space. Protease inhibitors are pretty traditional and very successful types of drugs that will be stiff competition.


Medivir Signs Research & Development Collaboration on Dengue Virus

14-Feb-11 Highlights of the Collaboration:

· Collaboration with Janssen Pharmaceutica N.V. focused on dengue virus
· Both parties to contribute 50:50 resources to the research program
· Strengthens Medivir’s presence in infectious diseases and utilises strong know-how in the discovery of protease inhibitor drugs



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News